These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8418245)

  • 1. Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study.
    Dugan M; Choy D; Ngai A; Sham J; Choi P; Shiu W; Leung T; Teo P; Prasad U; Lee S
    J Clin Oncol; 1993 Jan; 11(1):70-6. PubMed ID: 8418245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
    Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
    J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
    Silver RT; Case DC; Wheeler RH; Miller TP; Stein RS; Stuart JJ; Peterson BA; Rivkin SE; Golomb HM; Costanzi
    J Clin Oncol; 1991 May; 9(5):754-61. PubMed ID: 2016617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
    Cowan JD; Neidhart J; McClure S; Coltman CA; Gumbart C; Martino S; Hutchins LF; Stephens RL; Vaughan CB; Osborne CK
    J Natl Cancer Inst; 1991 Aug; 83(15):1077-84. PubMed ID: 1875415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma].
    Huang HQ; Zhou ZM; Li YH; Jiang WQ; He YJ; Teng XY; Guan ZZ
    Ai Zheng; 2002 Apr; 21(4):409-11. PubMed ID: 12452022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone as single agent in the treatment of advanced breast cancer: clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Thansakul A; Jirapanuwat S; Skulchan V; Rojananin S; Chantarakul N
    J Med Assoc Thai; 1989 Feb; 72(2):82-9. PubMed ID: 2738491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.
    Sparano JA; Robert N; Silverman P; Lazarus H; Malik U; Venkatraj U; Sarta C
    J Clin Oncol; 1996 Sep; 14(9):2576-83. PubMed ID: 8823338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
    Johnson FM; Garden A; Palmer JL; Kies M; Clayman G; Brumfield B; Khuri FR; Morrison W; Papadimitrakopoulou V; Diaz EM; Glisson BS
    Cancer; 2004 Mar; 100(5):991-8. PubMed ID: 14983495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.
    Siu LL; Czaykowski PM; Tannock IF
    J Clin Oncol; 1998 Jul; 16(7):2514-21. PubMed ID: 9667272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Oral Oncol; 2005 Jul; 41(6):589-95. PubMed ID: 15975521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma.
    Poon D; Chowbay B; Cheung YB; Leong SS; Tan EH
    Cancer; 2005 Feb; 103(3):576-81. PubMed ID: 15612023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study.
    al-Sarraf M; Pajak TF; Cooper JS; Mohiuddin M; Herskovic A; Ager PJ
    J Clin Oncol; 1990 Aug; 8(8):1342-51. PubMed ID: 2199621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.
    Chan AT; Hsu MM; Goh BC; Hui EP; Liu TW; Millward MJ; Hong RL; Whang-Peng J; Ma BB; To KF; Mueser M; Amellal N; Lin X; Chang AY
    J Clin Oncol; 2005 May; 23(15):3568-76. PubMed ID: 15809453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic studies with mitoxantrone in the treatment of patients with nasopharyngeal carcinoma.
    Hu OY; Chang SP; Law CK; Jian JM; Chen KY
    Cancer; 1992 Feb; 69(4):847-53. PubMed ID: 1735075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.